Aclarion, Inc. SEC filings ACON

Aclarion, Inc. has 276 filings in SEC EDGAR's recent list, going back to Mar 3, 2015. Its latest annual report, Form 10-K, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jun 4, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

Aclarion, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Aug 19, 2026 Aug 17, 2026
4 Insider transaction Aug 18, 2026 Aug 14, 2026
4 Insider transaction Aug 17, 2026 Aug 13, 2026
4 Insider transaction Aug 17, 2026 Aug 13, 2026
4 Insider transaction Aug 17, 2026 Aug 13, 2026
4 Insider transaction Aug 17, 2026 Aug 13, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction May 12, 2026 May 12, 2026
4 Insider transaction May 12, 2026 May 11, 2026
4 Insider transaction May 11, 2026 May 11, 2026
4 Insider transaction May 8, 2026 May 6, 2026
SCHEDULE 13G Ownership over 5% (passive) Mar 25, 2026 —
4 Insider transaction Dec 1, 2025 Nov 26, 2025
4 Insider transaction Sep 3, 2025 Sep 2, 2025
3 Initial insider ownership Sep 3, 2025 Sep 2, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jan 21, 2025 —
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
SC 13G Ownership over 5% (passive) Sep 5, 2024 —
SC 13G/A Amended ownership over 5% (passive) Mar 29, 2024 —
SC 13G Ownership over 5% (passive) Mar 6, 2024 —
SC 13G Ownership over 5% (passive) Jan 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Dec 29, 2023 —
SC 13G Ownership over 5% (passive) Oct 30, 2023 —
4 Insider transaction Mar 28, 2023 Mar 28, 2023
4 Insider transaction Feb 21, 2023 Feb 16, 2023
SC 13G Ownership over 5% (passive) Feb 3, 2023 —
4 Insider transaction Dec 29, 2022 Dec 28, 2022
4 Insider transaction Dec 29, 2022 Dec 29, 2022
4 Insider transaction Dec 29, 2022 Dec 29, 2022
4/A Filing Dec 8, 2022 Dec 2, 2022
4 Insider transaction Dec 6, 2022 Dec 2, 2022
4 Insider transaction Dec 6, 2022 Dec 2, 2022
4 Insider transaction Sep 15, 2022 Sep 15, 2022
4 Insider transaction Sep 15, 2022 Sep 15, 2022
4 Insider transaction Sep 15, 2022 Sep 15, 2022
3/A Form 3/a submission May 23, 2022 Apr 21, 2022
3/A Filing May 19, 2022 Apr 21, 2022
4 Insider transaction Apr 25, 2022 Apr 22, 2022
4 Insider transaction Apr 25, 2022 Apr 21, 2022
3/A Filing Apr 25, 2022 Apr 21, 2022
4 Insider transaction Apr 25, 2022 Apr 21, 2022
4 Insider transaction Apr 25, 2022 Apr 21, 2022
3 Initial insider ownership Apr 22, 2022 Apr 21, 2022
3 Initial insider ownership Apr 22, 2022 Apr 21, 2022
4 Insider transaction Apr 22, 2022 Apr 22, 2022
4 Insider transaction Apr 22, 2022 Apr 22, 2022
4 Insider transaction Apr 22, 2022 Apr 22, 2022
3 Initial insider ownership Apr 22, 2022 Apr 21, 2022
3 Initial insider ownership Apr 22, 2022 Apr 21, 2022
3 Initial insider ownership Apr 21, 2022 Apr 21, 2022
3 Initial insider ownership Apr 21, 2022 Apr 21, 2022
3 Initial insider ownership Apr 21, 2022 Apr 21, 2022
3 Initial insider ownership Apr 21, 2022 Apr 21, 2022
3 Initial insider ownership Apr 21, 2022 Apr 21, 2022
3 Initial insider ownership Apr 21, 2022 Apr 21, 2022
3 Initial insider ownership Apr 21, 2022 Apr 21, 2022

Showing 65 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
ACON (Nasdaq), ACONW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Broomfield, CO
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1635077
Former names
Nocimed, Inc. (until Oct 26, 2021)

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.